WELLS FARGO & COMPANY/MN

Position in HALO — Halozyme Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Back to HALO Full portfolio

Position in HALO

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$99,254,679

+$4,663,388 QoQ

Shares Held

1,535,737

+9.3% QoQ

Ownership

1.29%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.48311462183955.ToString("F0")% Shared 0.ToString("F0")% None 0.5168853781604532.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. HALO ranks #4 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,995	$332,670,066
2	ALNY	Alnylam Pharmaceuticals, Inc.	342,763	$113,409,991
3	REGN	Regeneron Pharmaceuticals, Inc.	142,021	$109,731,102
4	HALO	Halozyme Therapeutics, Inc. This page	1,535,737	$99,254,679
5	INSM	INSMED Inc	597,384	$97,684,229
6	ASND	Ascendis Pharma A/S	154,199	$35,269,936
7	EXEL	Exelixis, Inc.	687,304	$29,478,466
8	ARGX	Argenx SE	38,104	$27,825,444

All Filings in HALO

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$99,254,679	1,535,737	+9.3%	Shares	Defined	2026-05-11
2025-12-31	$94,591,291	1,405,517	+140.0%	Shares	Defined	2026-02-13
2025-09-30	$42,952,302	585,660	-15.4%	Shares	Defined	2025-11-13
2025-06-30	$36,005,797	692,153	+11.0%	Shares	Defined	2025-08-14
2025-03-31	$39,783,300	623,465	-13.0%	Shares	Defined	2025-05-13
2024-12-31	$34,243,720	716,246	+1.7%	Shares	Defined	2025-02-13
2024-09-30	$40,293,582	703,941	+8.9%	Shares	Defined	2024-11-13
2024-06-30	$33,837,910	646,255	+1.4%	Shares	Defined	2024-08-13
2024-03-31	$25,924,385	637,276	-3.0%	Shares	Defined	2024-05-10
2023-12-31	$24,271,038	656,684	-2.7%	Shares	Defined	2024-02-09
2023-09-30	$25,778,849	674,839	-3.3%	Shares	Defined	2023-11-13
2023-06-30	$25,175,307	697,957	+12.0%	Shares	Defined	2023-08-15
2023-03-31	$23,805,200	623,336	+34.9%	Shares	Defined	2023-05-12
2022-12-31	$26,287,912	462,002	-26.8%	Shares	Defined	2023-02-13
2022-09-30	$24,943,293	630,837	+287.4%	Shares	Defined	2022-11-14
2022-06-30	$7,164,916	162,839	-62.9%	Shares	Defined	2022-08-12
2022-03-31	$17,513,897	439,165	-8.7%	Shares	Defined	2022-05-16
2021-12-31	$19,350,458	481,235	-64.4%	Shares	Defined	2022-02-14
2021-09-30	$55,020,795	1,352,527	+18.4%	Shares	Defined	2021-11-15
2021-06-30	$51,888,824	1,142,674	+3.7%	Shares	Defined	2021-08-16
2021-03-31	$45,924,450	1,101,570	-4.5%	Shares	Defined	2021-05-13
2020-12-31	$49,256,287	1,153,273	-11.1%	Shares	Defined	2021-02-09
2020-09-30	$34,074,041	1,296,577	+7.3%	Shares	Defined	2020-11-05
2020-06-30	$32,401,384	1,208,556	+8.9%	Shares	Defined	2020-08-13
2020-03-31	$19,963,825	1,109,718	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.